DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
EYPT EyePoint Pharmaceuticals
- 7.125
- -0.315-4.23%
Trading Dec 19 12:53 ET
486.29MMarket Cap-3.58P/E (TTM)
7.540High7.040Low502.20KVolume7.540Open7.440Pre Close3.66MTurnover1.07%Turnover RatioLossP/E (Static)68.25MShares30.99052wk High2.22P/B333.56MFloat Cap7.04052wk Low--Dividend TTM46.82MShs Float72.200Historical High--Div YieldTTM6.72%Amplitude2.190Historical Low7.281Avg Price1Lot Size
About EyePoint Pharmaceuticals Company
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Company Profile
SymbolEYPT
Company NameEyePoint Pharmaceuticals
Listing DateJan 27, 2005
Founded1987
CEODr. Jay S. Duker, M.D.
MarketNASDAQ
Employees121
Fiscal Year Ends12-31
Address480 Pleasant Street,Suite A-210
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-926-5000
Company Executives
- Name
- Position
- Salary
- Dr. Jay S. Duker, M.D.
- Director, President and Chief Executive Officer
- 2.92M
- George O. Elston
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 1.78M
- Dr. Ramiro Ribeiro, M.D.,PhD
- Chief Medical Officer
- --
- Nancy S. Lurker
- Executive Vice Chairman of the Board
- 3.74M
- Dr. Goran A. Ando, M.D.
- Chairman of the Board
- 214.78K
- Fred Hassan
- Director
- --
- Dr. John B. Landis, PhD
- Director
- 161.67K
- Wendy F. DiCicco
- Independent Director
- 171.67K
- Stuart M. Duty
- Independent Director
- 381.10K
- Karen Zaderej
- Independent Director
- 149.17K